The Na+/H+ exchanger: A target for cardiac therapeutic intervention

Current Drug Targets - Cardiovascular and Haematological Disorders

Volumn 5, Issue 4, 2005, Pages 323-335

  Karmazyn, M ^a   Sawyer, M ^b   Fliegel, L ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

(3 METHYLSULFONYL 4 PIPERIDINOBENZOYL)GUANIDINE METHANESULFONATE; 1 (3,4 DIHYDRO 4 ISOPROPYL 2,2 DIMETHYL 3 OXO 2H 1,4 BENZOXAZINE 6 CARBONYL)GUANIDINE; [4 [4 (2 FUROYL) 1 PIPERAZINYL] 3 (METHYLSULFONYL)BENZOYL]GUANIDINE; AMILORIDE; AMILORIDE DERIVATIVE; AMINO ACID; BIIB 722; CALCIUM ION; CARDIOVASCULAR AGENT; CARIPORIDE; EMD 87580; ENIPORIDE; GUANIDINE DERIVATIVE; ISOPROTEIN; PROTEIN INHIBITOR; PROTON; SM 20220; SODIUM CHANNEL AFFECTING AGENT; SODIUM ION; SODIUM PROTON EXCHANGE PROTEIN 1; SODIUM PROTON EXCHANGE PROTEIN 1 INHIBITOR; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; CATION EXCHANGE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; DRUG DOSE REGIMEN; DRUG MECHANISM; DRUG TARGETING; HEART HYPERTROPHY; HEART INFARCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN DOMAIN; PROTEIN LOCALIZATION; REVIEW; SIDE EFFECT;

ANIMALS; DRUG DELIVERY SYSTEMS; HEART DISEASES; HUMANS; MUTATION; PROTEIN ISOFORMS; SODIUM-HYDROGEN ANTIPORTER;

EID: 23644439766     PISSN: 15680061     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568006054553417     Document Type: Review

References (116)

1. Fliegel, L. The Na(+)/H(+) exchanger isoform 1. Int. J. Biochem. Cell Biol., 2005, 37, 33-37.
2. + antiporter. Cell, 1989, 56, 271-280.
3. + Exchanger, From Molecular to Its Role in Disease, edited by M. Karmazyn, M. Avkiran and L. Fliegel, Kluwer academic Publishers, Boston/Dordrecht/London, 2003, pp. 17-34.
4. + exchanger. FEBS Lett., 1991, 279, 25-29.
5. Cavet, M.E., Akhter, S., Murtazina, R., Sanchez de Medina, F., Tse, C.M., Donowitz, M. Half-lives of plasma membrane Na(+)/H(+) exchangers NHE1-3: plasma membrane NHE2 has a rapid rate of degradation. Am. J. Physiol. Cell. Physiol., 2001, 281, C2039-C2048.
6. + exchanger isoform. Am. J. Physiol., 1997, 272, C90-98.
7. + exchanger isoform 5 (NHE5) from human brain. J. Biol. Chem., 1999, 274, 4377-4382.
8. Brett, C.L., Wei, Y., Donowitz, M., Rao, R. Human Na(+)/H(+) exchanger isoform 6 is found in recycling endosomes of cells, not in mitochondria. Am J Physiol Cell Physiol, 2002, 282, C1031-1041.
9. + exchanger localized to the trans-Golgi network. J. Biol. Chem., 2001, 276, 17387-17394.
10. + exchanger isoform NHE8. Am. J. Physiol. Renal. Physiol., 2003, 284, F467-473.
11. + exchanger isoforms are distributed to golgi and post-golgi compartments and are involved in organelle pH regulation. J. Biol. Chem., 2005, 280, 1561-1572.
12. + exchanger NHE-1 possesses N- and O-linked glycosylation restricted to the first N-terminal extracellular domain. Biochem., 1994, 33, 10463-10469.
13. + exchanger isoforms NHE1 and NHE3 exist as stable dimers in membranes with a high degree of specificity for homodimers. J. Biol. Chem., 1994, 269, 2589-2596.
14. Li, X., Liu, Y., Kay, C.M., Muller-Esterl, W., Fliegel, L. The Na(+)/H(+) exchanger cytoplasmic tail: Structure, function, and interactions with tescalcin. Biochemistry, 2003, 42, 7448-7456.
15. + exchanger isoform 1. J. Biol. Chem., 2000, 275, 7942-7949.
16. + exchanger. Biochem. Cell Biol., 1998, 76, 837-842.
17. + antiporter cytoplasmic domain mediates growth factor signals and controls "H(+)-sensing". Proc. Natl. Acad. Sci. USA, 1992, 89, 2424-2428.
18. + exchanger, NHE1: structure, regulation, and cellular actions. Annu. Rev. Pharmacol. Toxicol., 2002, 42, 527-552.
19. + and amiloride. Evidence for a modifier site. J. Biol. Chem., 1983, 258, 9710-9716.
20. + exchanger in the rat myocardium by MAP-kinase-dependent pathways. J. Biol. Chem., 1999, 274, 22985-22992.
21. + exchange and ERK1/2. Circ. Res., 1998, 83, 824-831.
22. + antiporter, glycoprotein of 110 kD. Science, 1990, 247, 723-726.
23. + exchanger, NHE-1, by phosphorylating a set of common sites. J. Biol. Chem., 1991, 266, 19166-19171.
24. + antiporter during cell volume regulation. Evidence for a phosphorylation- independent mechanism. J. Biol. Chem., 1992, 267, 23823-23828.
25. Aharonovitz, O., Zaun, H.C., Balla, T., York, J.D., Orlowski, J., Grinstein, S. Intracellular pH regulation by Na(+)/H(+) exchange requires phosphatidylinositol 4,5-bisphosphate. J. Cell Biol., 2000, 150, 213-224.
26. Denker, S.P., Huang, D.C., Orlowski, J., Furthmayr, H., Barber, D.L. Direct binding of the Na--H exchanger NHE1 to ERM proteins regulates the cortical cytoskeleton and cell shape independently of H(+) translocation. Mol. Cell., 2000, 6, 1425-1436.
27. Denker, S.P., Barber, D.L. Cell migration requires both ion translocation and cytoskeletal anchoring by the Na-H exchanger NHE1. J. Cell Biol., 2002, 159, 1087-1096.
28. Baumgartner, M., Patel, H., Barber, D.L. Na(+)/H(+) exchanger NHE1 as plasma membrane scaffold in the assembly of signaling complexes. Am. J. Physiol. Cell Physiol., 2004, 287, C844-850.
29. + exchangers. J. Biol. Chem., 2001, 276, 17367-17372.
30. + exchange. J. Biol. Chem., 1996, 93, 12631-12636.
31. + exchanger. J. Biol. Chem., 2002, 277, 43771-43777.
32. + exchanger isoform 1 (NHE1) is a novel member of the calmodulin-binding proteins. J. Biol. Chem., 1994, 269, 13703-13709.
33. 2+ regulation-defective. J. Biol. Chem., 1994, 269, 13710-13715.
34. + exchanger. Biochemistry, 2004, 43, 16477-16486.
35. + exchanger NHE1 by sustained intracellular acidosis. Evidence for a novel mechanism mediated by the ERK pathway. J. Biol. Chem., 2003, 278, 31676-31684.
36. + exchanger activity. Basic Res. Cardiol., 2001, 96, 301-305.
37. + exchanger through mitogen-activated protein kinase. Biochemistry, 1997, 36, 9151-9158.
38. + exchanger isoform- 1. J. Biol. Chem., 1999, 274, 20206-20214.
39. Tominaga, T., Ishizaki, T., Narumiya, S., Barber, D.L. p160ROCK mediates RhoA activation of Na-H exchange. EMBO J., 1998, 17, 4712-4722.
40. + exchanger NHE1 and regulates NHE1 activation by platelet-derived growth factor. J. Biol. Chem., 2001, 276, 31349-31356.
41. Khaled, A.R., Moor, A.N., Li, A., Kim, K., Ferris, D.K., Muegge, K., Fisher, R.J., Fliegel, L., Durum, S.K. Trophic factor withdrawal: p38 mitogen-activated protein kinase activates NHE1, which induces intracellular alkalinization. Mol. Cell. Biol., 2001, 21, 7545-7557.
42. Haworth, R.S., Sinnett-Smith, J., Rozengurt, E., Avkiran, M. Protein kinase D inhibits plasma membrane Na(+)/H(+) exchanger activity. Am. J. Physiol., 1999, 277, C1202-1209.
43. 2+ /calmodulin-dependent protein kinase II. Biochem. J., 1992, 282, 139-145.
44. + exchanger. J. Biol. Chem., 2002, 277, 36085-36091.
45. Mailander, J., Muller-Esterl, W., Dedio, J. Human homolog of mouse tescalcin associates with Na(+)/H(+) exchanger type-1. FEBS Lett., 2001, 507, 331-335.
46. + exchanger in renal microvillus membrane vesicles. Nature, 1982, 299, 161-163.
47. + exchanger 1. J. Biol. Chem., 2003, 278, 11828-11835.
48. + exchange-dependent increase in intracellular pH times G2/M entry and transition. J. Biol. Chem., 2003, 278, 44645-44649.
49. + antiporter potentiates growth and retinoic- acid induced differentiation of P19 embryonal carcinoma cells. J. Biol. Chem., 1997, 272, 26545-26549.
50. Bell, S.M., Schreiner, C.M., Schultheis, P.J., Miller, M.L., Evans, R.L., Vorhees, C.V., Shull, G.E., Scott, W.J. Targeted disruption of the murine Nhe1 focus induces ataxia, growth retardation, and seizures. Am. J. Physiol., 1999, 276, C788-C795.
51. + translocation. Molecular Cell, 2000, 8, 1425-1436.
52. + exchanger recruits ezrin/radixin /moesin proteins to regulate Akt-dependent cell survival. J. Biol. Chem., 2004, 279, 26280-26286.
53. Rich, I.N., Worthington-White, D., Garden, O.A., Musk, P. Apoptosis of leukemic cells accompanies reduction in intracellular pH after targeted inhibition of the Na(+)/H(+) exchanger. Blood, 2000, 95, 1427-1434.
54. + exchange. Structure, regulation, and its role in heart disease. Circ. Res., 1999, 85, 777-786.
55. + exchanger: a potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation of postinfarction heart failure. Drugs, 2001, 61, 375-389.
56. 2+ exchanger increases susceptibility to ischemia/reperfusion injury in male, but not female, transgenic mice. Circ. Res., 1998, 83, 1215-1223.
57. + exchange inhibition in hypertrophied myocardium subjected to cardioplegic arrest: an effective cardioprotective approach. Eur. J. Cardiothorac. Surg., 2005, 27, 111-116.
58. + exchanger are resistant to cardiac ischemia-reperfusion injury. Circ. Res., 2003, 93, 776-782.
59. Scholz, W., Albus, U., Counillon, L., Gogelein, H., Lang, H.J., Linz, W., Weichert, A., Scholkens, B.A. Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc. Res., 1995, 29, 260-268.
60. + exchange inhibition. Drug. Dev. Res., 2002, 55, 22-28.
61. Gumina, R.J., Gross, G.J. If ischemic preconditioning is the gold standard, has a platinum standard of cardioprotection arrived? Comparison with NHE inhibition. J. Thromb. Thrombolysis, 1999, 8, 39-44.
62. Murry, C.E., Richard, V.J., Reimer, K.A., Jennings, R.B. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ. Res., 1990, 66, 913-931.
63. + exchanger activity does not contribute to protection by ischemic preconditioning in the isolated rat heart. Circulation, 1997, 96, 3617-3625.
64. Gumina, R.J., Buerger, E., Eickmeier, C., Moore, J., Daemmgen, J., Gross, G.J. Inhibition of the Na(+)/H(+) exchanger confers greater cardioprotection against 90 minutes of myocardial ischemia than ischemic preconditioning in dogs. Circulation, 1999, 100, 2519-2526.
65. Theroux, P., Chaitman, B.R., Danchin, N., Erhardt, L., Meinertz, T., Schroeder, J.S., Tognoni, G., White, H.D., Willerson, J.T., Jessel, A. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators. Circulation, 2000, 102, 3032-3038.
66. Zeymer, U., Suryapranata, H., Monassier, J.P., Opolski, G., Davies, J., Rasmanis, G., Linssen, G., Tebbe, U., Schroder, R., Tiemann, R., Machnig, T., Neuhaus, K.L. The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. J. Am. Coll. Cardiol., 2001, 38, 1644-1650.
67. Rupprecht, H.J., vom Dahl, J., Terres, W., Seyfarth, K.M., Richardt, G., Schultheibeta, H.P., Buerke, M., Sheehan, F.H., Drexler, H. Cardioprotective effects of the Na(+)/H(+) exchange inhibitor cariporide in patients with acute anterior myocardial infarction undergoing direct PTCA. Circulation, 2000, 101, 2902-2908.
68. + exchange inhibition by cariporide on death and nonfatal myocardial infarction in patients undergoing coronatry artery bypass graft surgery: The Expedition study. Circulation, 2003, 108, 2723 (Abstract).
69. Katz, A.M. Heart Failure. Pathophysiology, molecular biology, and clinical management. Lippincott Williams & Wilkins: Philadelphia, 2003.
70. + exchange in cardiac myocytes. Am. J. Physiol., 1992, 263, C1096-C1102.
71. Puceat, M., Vassort G. Neurohumoral modulation of intracellular pH in the heart. Cardiovasc. Res., 1995, 29, 178-183.
72. + exchanger activity in rat ventricular myocytes: evidence for selective mediation by the alphaIA-adrenoceptor subtype. Circ. Res., 1998, 82, 1078-1085.
73. Matsui, H., Barry, W.B., Livsey, C., Spitzer, K.W. Angiotension II stimulates sodium-hydrogen exchange in adult rabbit ventricular myocytes. Cardiovasc. Res., 1995, 29, 215-221.
74. Boston, D.R., Koyama, T., Rodriguez-Larrain, J., Zou, A., Su, Z., Barry, W.H. Effects of angiotensin II on intracellular calcium and contracture in metabolically inhibited cardiomyocytes. J. Pharmacol. Exp. Ther., 1998, 285, 716-723.
75. Mattiazzi, A., Perez, N.G., Vila-Petroff, M.G., Alvarez, B., Camilion de Hurtado, M.C., Cingolani, H.E. Dissociation between positive inotropic and alkalinizing effects of angiotensin II in feline myocardium. Am. J. Physiol., 1997, 272, H1131-1136.
76. + exchange in mediating effects of endothlin-1 on normal and ischemic /reperfused hearts. Circ. Res., 1994, 75, 369-378.
77. + exchange in dog cardiac purkinje fibres. J. Physiol., 1993, 471, 583-597.
78. + exchange is impaired in cardiac hypertrophy. J. Clin. Invest., 1997, 99, 125-135.
79. Yamazaki, T., Komuro, I., Kudoh, S., Zou, Y., Nagai, R., Aikawa, R., Uozumi, H., Yazaki, Y. Role of ion channels and exchangers in mechanical stretch-induced cardiomyocyte hypertrophy. Circ. Res., 1998, 82, 430-437.
80. Cingolani, H.E., Alvarez, B.V., Ennis, I.L., Camilion de Hurtado, M.C. Stretch-induced alkalinization of feline papillary muscle: an autocrine-paracrine system. Circ. Res., 1998, 83, 775-780.
81. + exchange in norepinephrine-induced protein synthesis in neonatal cultured rat cardiomyocytes. Jpn. Circ. J., 1990, 54, 535-539.
82. + exchanger and cardiac hypertrophy [editorial]. Circ. Res., 1998, 83, 870-873.
83. + exchange hyperactivity and myocardial hypertrophy: are they linked phenomena? Cardiovasc. Res., 1999, 44, 462-467.
84. Xia, Y., Rajapurohitam, V., Cook, M.A., Karmazyn, M. Inhibition of phenylephrine induced hypertrophy in rat neonatal cardiomyocytes by the mitochondrial KATP channel opener diazoxide. J. Mol. Cell. Cardiol., 2004, 37, 1063-1067.
85. Schluter, K.D., Schafer, M., Balser, C., Taimor, G., Piper, H.M. Influence of pHi and creatine phosphate on alpha-adrenoceptor-mediated cardiac hypertrophy. J. Mol. Cell. Cardiol., 1998, 30, 763-771.
86. Hasegawa, S., Nakano, M., Taniguchi, Y., Imai, S., Murata, K., Suzuki, T. Effects of Na(+)-H+ exchange blocker amiloride on left ventricular remodeling after anterior myocardial infarction in rats. Cardiovasc. Drugs Ther., 1995, 9, 823-826.
87. Taniguchi, Y., Nakano, M., Hasegawa, S., Kanda, T., Imai, S., Suzuki, T., Kobayashi, I., Nagai, R. Beneficial effect of amiloride, A Na(+)-H+ exchange blocker, in a murine model of dilated cardiomyopathy. Res. Commun. Mol. Pathol. Pharmacol., 1996, 92, 201-210.
88. Yoshida, H., Karmazyn, M. Na(+)/H(+) exchange inhibition attenuates hypertrophy and heart failure in 1-wk postinfarction rat myocardium. Am. J. Physiol., 2000, 278, H300-H3004.
89. Kusumoto, K., Haist, J.V., Karmazyn, M. Na(+)/H(+) exchange inhibition reduces hypertrophy and heart failure after myocardial infarction in rats. Am. J. Physiol., 2001, 280, H738-H745.
90. Spitznagel, H., Chung, O., Xia, Q., Rossius, B., Illner, S., Jahnichen, G., Sandmann, S., Reinecke, A., Daemen, M.J., Unger, T. Cardioprotective effects of the Na(+)/H(+)-exchange inhibitor cariporide in infarct-induced heart failure. Cardiovasc. Res., 2000, 46, 102-110.
91. + exchange inhibitor cariporide. J. Pharmacol. Exp. Ther., 2001, 298, 469-476.
92. Ennis, I.L., Alvarez, B.V., Camilion de Hurtado, M.C., Cingolani, H.E. Enalapril induces regression of cardiac hypertrophy and normalization of pHi regulatory mechanisms. Hypertension, 1998, 31, 961-967.
93. Engelhardt, S., Hein, L., Keller, U., Klambt, K., Lohse, M.J. Inhibition of Na(+)-H(+) exchange prevents hypertrophy, fibrosis, and heart failure in beta(1)-adrenergic receptor transgenic mice. Circ. Res., 2002, 90, 814-819.
94. + exchanger inhibition. Hypertension, 2003, 41, 1324-1329.
95. + exchanger attenuates the deterioration of ventricular function during pacing-induced heart failure in rabbits. Cardiovasc. Res., 2004, 63, 273-282.
96. Karmazyn, M., Liu, Q., Gan, X.T., Brix, B.J., Fliegel, L. Aldosterone increases NHE-1 expression and induces NHE-1-dependent hypertrophy in neonatal rat ventricular myocytes. Hypertension, 2003, 42, 1171-1176.
97. Fujisawa, G., Okada, K., Muto, S., Fujita, N., Itabashi, N., Kusano, E., Ishibashi, S. Na/H exchange isoform 1 is involved in mineralocorticoid/salt-induced cardiac injury. Hypertension, 2003, 41, 493-498.
98. Chen, L., Chen, C.X., Gan, X.T., Beier, N., Scholz, W., Karmazyn, M. Inhibition and reversal of myocardial infarction-induced hypertrophy and heart failure by NHE-1 inhibition. Am. J. Physiol. Heart Circ. Physiol., 2004, 286, H381-387.
99. Hayasaki-Kajiwara, Y., Kitano, Y., Iwasaki, T., Shimamura, T., Naya, N., Iwaki, K., Nakajima, M. Na(+)influx via Na(+)/H(+)exchange activates protein kinase C isozymes delta and epsilon in cultured neonatal rat cardiac myocytes. J. Mol. Cell. Cardiol., 1999, 31, 1559-1572.
100. +-exchanger attenuates cardiac hypertrophy and prevents cellular remodeling in heart failure. Cardiovasc. Res., 2005, 65, 83-92.
101. +-exchange activity is the cause of increased [Na+]i and underlies disturbed calcium handling in the rabbit pressure and volume overload heart failure model. Cardiovasc. Res., 2003, 57, 1015-1024.
102. Javadov, S., Huang, C., Kirshenbaum, L., Karmazyn, M. NHE-1 inhibition improves impaired mitochondrial permeability transition and respiratory function during postinfarction remodelling in the rat. J. Mol. Cell. Cardiol., 2005, 38, 135-143.
103. + exchanger. Int. J. Mol. Med., 1999, 3, 315-321.
104. Kleyman, T.R., Cragoe, E.J.J. Amiloride and its analogs as tools in the study of ion transport. J. Mem. Biol., 1988, 105, 1-21.
105. + exchange inhibitor and its effects in cardiac ischaemia. Br. J. Pharmacol., 1993, 109, 562-568.
106. + Exchanger, From Molecular to Its Role in Disease, edited by M. Karmazyn, M. Avkiran and L. Fliegel, Kluwer academic Publishers, Boston/Dordrecht/London, 2003; pp. 239-253.
107. + exchanger that confer sensitivity to pharmacological antagonists. J. Biol. Chem., 1996, 271, 19922-19927.
108. + exchanger gene (NHE1) and amplification of the mutated allele confer amiloride resistance upon chronic acidosis. Proc. Natl. Acad. Sci. U.S.A., 1993, 90, 4508-4512.
109. + exchanger-1. Biochemistry, 1997, 36, 2951-2959.
110. + exchanger reveal the participation of TM4 into a highly constrained sodium-binding site. Biochemistry, 2001, 40, 5095-5101.
111. + exchanger. J. Biol. Chem., 2005, 280, 17863-17872.
112. Sansom, M.S. Proline residues in transmembrane helices of channel and transport proteins: a molecular modelling study. Protein Eng., 1992, 5, 53-60.
113. + exchanger isoform 1. Biochem. J., 2004, 379, 31-38.
114. + exchanger. Am. J. Physiol., 1995, 269, C392-C402.
115. + and the interaction with amiloride derivatives. Biochemistry, 2003, 42, 15361-15368.
116. + exchanger. Eur. J. Biochem., 2001, 268, 1-13.